Shows level 2 now on

Scrolling through these fresh stats from BrightLocal's recent report, you can almost hear the alarm bells echoing across small towns and city squares. The data paints a surprisingly sobering picture: despite the fact that 71% of folks are heading straight to Google to find local businesses, only a mere 22% of small business owners are tagging it as one of their top tools...

Blending the Old with the New Here's an interesting tidbit for all you watch aficionados and investors: Casio is set to drop the GMC-2500 and GAC-2500, a new wave of G-SHOCK watches that are marrying that vintage cool with today's swagger. Straight out of Tokyo, these timepieces are taking a page from the 1983 DW-5000C playbook, but the twist? They're going analog. It's a...

Diving Into the M&A Controversy On the bustling streets of New York, beneath the towering Empire State Building, a plot unfolds that could shake the foundations of your investments—particularly if you're holding shares in Synaptics, Eagle Financial, Victory Capital, or Centerspace. Juan Monteverde and his legal firepower from Monteverde & Associates PC are launching a...

RZ-001's European Success: A New Frontier Look, when a biopharmaceutical firm's RNA-editing therapy snags an Orphan Medicinal Product Designation from the European Commission, it's not just some clipboard milestone—it's a heavy-hitter move. That's exactly what Rznomics, the South Korean gene therapy player, pulled off with RZ-001. Now, we aren't just seeing paperwork...

Lung Cancer's Unseen Struggles and a Ray of Hope Not every day we get a chance to chew on the news of another initiative by the American Lung Association. They're ringing the bell again this year, focusing on the underutilized biomarker testing that could be the ticket to a longer life for lung cancer patients. When you dive into the stark figures, it hits hard. More than...

Picture this: You’re a big fish like Labcorp ready to feast on smaller catches. That’s exactly what’s rolling out as OPKO Health cuts a deal to offload a chunk of its BioReference Health assets to Labcorp for a tidy $722 million in cash. Assets on the Move OPKO’s BioReference Health has long been a player in the clinical testing world, with a focus on services...

Price Cuts Bring 3D Printing Mainstream Here's the deal—3D printing used to be the domain of the tech-savvy elite, akin to those early computer geeks holed up in garages. But now? Bambu Lab is throwing open those doors with its Black Friday and Cyber Monday specials, slashing prices like a man on a mission. They're bringing an entire technological leap into our hands,...

Highlight Introduces Pulse for Instant Insights Ever find yourself waiting forever for consumer feedback? Well, folks, Highlight's making sure those days are behind us with their new launch: Pulse. They've taken the conventional consumer testing model and flipped it on its head with Highlight Twins. Imagine getting the pulse of your audience in mere seconds, not the...

Anticipation Builds for Amcor's Q3 2026 Financials Well, here we are again, staring down the barrel of another quarterly earnings report from Amcor plc (NYSE: AMCR). They've circled November 4th, 2026, in red on their calendars to dish out the numbers after the U.S. market's last bell rings. Investors, analysts, and the peanut gallery will be tuning in, and why not? At a...

A Mural Tribute to Country Music Roots Forget about skyscrapers and bustling metropolises; sometimes, it's about bringing a bit of soul back to the heartland. That's precisely what the unveiling of the "Wildflowers and Wild Horses" mural in Philadelphia, Mississippi, did. Lainey Wilson and Marty Stuart's Vision Partners in crime — or, more fittingly, in country —...

Explore BCC Research's Presence at AUTM 2025 BCC Research is thrilled to announce its participation in the highly anticipated AUTM 2025 Annual Meeting in Washington, D.C. This premier event is scheduled to take place at the Gaylord National Resort and Convention Center from the 2nd to the 5th of March. The Association of University Technology Managers, or AUTM, plays a...

Nurix Therapeutics Inc. (NASDAQ: NRIX) stirred up chatter in the biopharma world a while back with its innovative focus on targeted protein degradation (TPD) therapies. Investors were tuning in, especially after seeing the company pivot toward addressing serious diseases that just won’t quit. This wasn't just another biotech flash in the pan—Nurix was positioning...

Brian Tyler Takes the Helm at Fresh Blends® Fresh Blends®, renowned for its innovative self-serve frozen and iced beverage solutions, has made a significant leadership change with the appointment of Brian Tyler as its new Chief Executive Officer. Tyler, who has previously made his mark as Vice President at Bevolution Group, is set to guide Fresh Blends® into an...

Enzo Biochem Navigates Strategic Alternatives for Growth In recent developments, Enzo Biochem, Inc. (OTCQX: ENZB) has embarked on a significant journey to reassess its strategic options aimed at advancing shareholder value. This decision follows a wave of inquiries regarding potential transactions, prompting the Board of Directors to form a dedicated committee to explore...

ADNOC Gas Achieves Historic Financial Milestones ADNOC Gas plc, an integrated gas processing powerhouse, has marked an impressive year with a record net income of $5 billion for 2024. This striking figure underscores the company's strong performance and commitment to sustainable growth in the energy sector. Financial Performance Review for 2024 The company reported an...